Renalytix Shares Outstanding History (RENX)
Renalytix reported 331.2M shares outstanding at the end of fiscal 2025.
View full Renalytix company overviewRenalytix annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | 331.2M | 176.8M | +114.56% |
| 2024 | 2024-06-30 | 154.4M | 60.6M | +64.60% |
| 2023 | 2023-06-30 | 93.8M | 19.0M | +25.44% |
| 2022 | 2022-06-30 | 74.8M | 2.6M | +3.55% |
| 2021 | 2021-06-30 | 72.2M | 12.8M | +21.51% |
| 2020 | 2020-06-30 | 59.4M | 5.6M | +10.41% |
| 2019 | 2019-06-30 | 53.8M | — | — |
Renalytix quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | 437.0M | 105.8M | +31.95% |
| Q2 2025 | 2024-12-31 | 331.2M | 231.3M | +231.44% |
| Q1 2025 | 2024-09-30 | 165.9M | 72.1M | +76.93% |
| Q4 2024 | 2024-06-30 | 154.4M | 60.6M | +64.60% |
| Q3 2024 | 2024-03-31 | 119.9M | 26.1M | +27.87% |
| Q2 2024 | 2023-12-31 | 99.9M | — | — |
| Q1 2024 | 2023-09-30 | 93.8M | 18.9M | +25.22% |
| Q4 2023 | 2023-06-30 | 93.8M | 19.0M | +25.44% |
| Q3 2023 | 2023-03-31 | 93.8M | 21.5M | +29.70% |
| Q1 2023 | 2022-09-30 | 74.9M | — | — |
| Q4 2022 | 2022-06-30 | 74.8M | 2.6M | +3.55% |
| Q3 2022 | 2022-03-31 | 72.3M | — | — |
| Q4 2021 | 2021-06-30 | 72.2M | 12.8M | +21.51% |
| Q4 2020 | 2020-06-30 | 59.4M | 5.6M | +10.41% |
| Q4 2019 | 2019-06-30 | 53.8M | — | — |
Renalytix shares outstanding trends
Over the last five fiscal years, Renalytix's shares outstanding moved from 59.4M to 331.2M, a change of 271.8M. The latest reported quarter, Q2 2026, shows 437.0M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Renalytix source filings ↗